| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 687 |
| 1 | INTERFERON BETA-1A | 563 |
| 2 | ALENDRONATE SODIUM | 538 |
| 3 | ETANERCEPT | 389 |
| 4 | INFLIXIMAB | 369 |
| 5 | ERGOCALCIFEROL | 360 |
| 6 | METHOTREXATE SODIUM | 320 |
| 7 | LEVOTHYROXINE SODIUM | 313 |
| 8 | COPPER | 298 |
| 9 | METHOTREXATE | 289 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 116 | 0.0418 |
| 1 | ELAGOLIX AND ESTRADIOL AND NORETHISTERONE | 25 | 0.0417 |
| 2 | PSYLLIUM HUSK | 36 | 0.0266 |
| 3 | ELAGOLIX | 91 | 0.0244 |
| 4 | METHYLERGONOVINE MALEATE | 12 | 0.0197 |
| 5 | GOLIMUMAB | 160 | 0.0127 |
| 6 | ERGOCALCIFEROL | 360 | 0.0121 |
| 7 | INFLIXIMAB-DYYB | 40 | 0.0116 |
| 8 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 90 | 0.0098 |
| 9 | RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE | 12 | 0.0079 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 987 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 711 |
| 2 | Interferon beta [EPC] | 573 |
| 3 | Corticosteroid [EPC] | 487 |
| 4 | Benzodiazepine [EPC] | 455 |
| 5 | Estrogen [EPC] | 453 |
| 6 | Interleukin-23 Antagonist [EPC] | 375 |
| 7 | Vitamin C [EPC] | 368 |
| 8 | Provitamin D2 Compound [EPC] | 360 |
| 9 | Vitamin D [EPC] | 338 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 42 | 0.0610 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 28 | 0.0135 |
| 2 | Provitamin D2 Compound [EPC] | 360 | 0.0121 |
| 3 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 27 | 0.0070 |
| 4 | Copper-containing Intrauterine Device [EPC] | 300 | 0.0061 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 35 | 0.0050 |
| 6 | Oxytocic [EPC] | 14 | 0.0046 |
| 7 | Interleukin-23 Antagonist [EPC] | 375 | 0.0036 |
| 8 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 9 | Diagnostic Dye [EPC] | 2 | 0.0031 |